Noyszewski E A, Wroblewski K, Dodge G R, Kudchodkar S, Beers J, Sarma A V, Reddy R
University of Pennsylvania, Philadelphia 19104-6100, USA.
Arthritis Rheum. 2001 May;44(5):1089-95. doi: 10.1002/1529-0131(200105)44:5<1089::AID-ANR189>3.0.CO;2-9.
To determine the metabolic fate of glucosamine (GlcN) in intact articular cartilage tissue.
Intact articular cartilage explants were cultured for up to 13 days in Dulbecco's modified Eagle's medium supplemented with 1) 1-13C-labeled GlcN, 2) 1-13C-labeled glucose (Glc), or 3) no labeling. Every 3-4 days, samples were removed and frozen in liquid nitrogen for carbon-13 magnetic resonance spectroscopic (MRS) analysis. The metabolic products of the labeled precursors were determined from the MRS data based on resonance positions and comparison with known standards and published values.
GlcN was taken up by the chondrocytes and incorporated selectively into the hexosamine, but not the hexuronic acid, components of the glycosaminoglycan chains of articular cartilage proteoglycan. The data also demonstrated that GlcN is the substrate of choice for the galactosamine moieties of the chondroitin sulfates, incorporating at levels 300% higher than with an equivalent amount of labeled Glc.
The results indicate that GlcN facilitates the production of proteoglycan components that are synthesized through the hexosamine biochemical pathway.
确定氨基葡萄糖(GlcN)在完整关节软骨组织中的代谢命运。
将完整的关节软骨外植体在补充有以下物质的杜尔贝科改良伊格尔培养基中培养长达13天:1)1-13C标记的GlcN,2)1-13C标记的葡萄糖(Glc),或3)无标记物。每3 - 4天取出样本并在液氮中冷冻,用于碳-13磁共振波谱(MRS)分析。根据共振位置以及与已知标准物和已发表值的比较,从MRS数据中确定标记前体的代谢产物。
GlcN被软骨细胞摄取,并选择性地掺入关节软骨蛋白聚糖糖胺聚糖链的己糖胺而非己糖醛酸成分中。数据还表明,GlcN是硫酸软骨素半乳糖胺部分的首选底物,其掺入水平比等量标记的Glc高300%。
结果表明,GlcN有助于通过己糖胺生物化学途径合成蛋白聚糖成分。